In Nature this week: fatal pig virus sequenced and traced to bats, and more.
An unexpected Ancestry.com test result has led to a lawsuit against a retired obstetrician gynecologist, the Washington Post reports.
The Federal Bureau of Investigation researchers helped a museum in Boston analyze the DNA of a 4,000-year-old mummified head, the New York Times says.
US Centers for Disease Control and Prevention has examined the prevalence of resistant Enterobacteriaceae.
In Cell this week: two waves of Denisovan-human mixing, open chromatin accessibility patterns during embryogenesis, and more.
Physicians and prostate cancer patients are beginning to turn to genomic tests to guide treatment decisions, according to the Wall Street Journal.
The Weekly Standard writes that academic discussions regarding gene editing need to make way for activists and lobbyists.
The Huffington Post tells the story of a couple that received false positives after sending their DTC genetic data to a third-party analysis site.
In PNAS this week: population structure in Helicoverpa, AMP-activated protein kinase levels in nicotine-exposed mice, and more.
Retraction Watch reports that the Nature Methods paper finding off-target effects of the CRISPR/Cas9 gene-editing machinery has been retracted.
The authors of and the journal that published the sequencing study of the Atacama skeleton have responded to concerns over how the sample was obtained.
Science reports that Ohio State University cancer researcher Ching-Shih Chen resigned due to misconduct findings.
In PLOS this week: genetic drift influences diversity among pathogens, QTLs linked to benzimidazole sensitivity, and more.
The US Department of Agriculture says it won't regulate genome-edited plants.
Kyoto University investigator has been fired for research misconduct, while Nobel Laureate Shinya Yamanaka has been penalized for lack of oversight, Retraction Watch reports.
The Washington Post notes that some health professional are wary of complex direct-to-consumer genetic testing.
In Science this week: protein destabilizing mutations can drive evolution, and more.
Cancer researcher James Holland has died at 92, the New York Times reports.
Craig Venter and Human Longevity aim to uncover disease through sequencing and other tests to increase lifespans, CNBC says.
NPR's Goats and Soda blog examines bias against research in Africa.
In Nature this week: sequencing strategy for quantifying clonal origin and cell type at single-cell level, and more.
In a new study in Scientific Reports, researchers have classified fluid-filled spaces in connective tissues all over the body as a new organ called the interstitium.
A group of European scientists has created the Association for Responsible Research and Innovation in Genome Editing, Science reports.
Can genomics help archeologists study the past, Nature News asks, or is it getting in their way of understanding ancient cultures?
In Genome Research this week: maternal microbe transmission at birth, avian malaria parasites, and more.
An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.
NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.
At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.
Patricia Fara writes about childcare funding, and women in science and science history at NPR.